Definium Therapeutics, Inc.

NASDAQ:DFTX

Biotechnology

Healthcare
$29.38 -1.67%

-$0.41 today

Market cap
$4.02B
Beta
2.38
P/E (TTM)
-11.0
EPS (TTM)
-$2.18
52W Low $12.88High $26.15

Volume 1.92M

Average 2.67M

Price history

Definium Therapeutics, Inc. SEC filings

Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.

Price history

Dividend-adjusted closing price

Period change

+157.49%

Period high

$48.45

Period low

$10.68

Latest

$29.38

SEC filings

What has the company disclosed?

Browse annual, quarterly, and current reports and other filings by form type.

SEC Filings

Recent regulatory filings

FormFiling DateAccepted
SC 13GNov 13, 2026Nov 13, 2026
10-QNov 9, 2026Nov 9, 2026
8-KNov 9, 2026Nov 9, 2026
SC 13GNov 5, 2026Nov 5, 2026
4Sep 29, 2026Sep 29, 2026
4Sep 29, 2026Sep 29, 2026
4Sep 29, 2026Sep 29, 2026
4Sep 29, 2026Sep 29, 2026
4Sep 29, 2026Sep 29, 2026
4Sep 18, 2026Sep 18, 2026
4Sep 18, 2026Sep 18, 2026
4Sep 14, 2026Sep 14, 2026
4Sep 14, 2026Sep 14, 2026
4Sep 14, 2026Sep 14, 2026
4Sep 14, 2026Sep 14, 2026

Competitors

Who does Definium Therapeutics, Inc. compete with?

Open similar companies to compare their filings and price history.

Questions

Filing questions

Common questions about DFTX's filings, answered from its disclosures.

What is the latest DFTX filing?

The latest filing shown is SC 13G dated Nov 13, 2026.

How many recent filings does DFTX have?

Intrinsic Alpha currently shows 20 recent filings for DFTX.